Profile
Sascha Bucher is currently an Independent Non-Executive Director at Tarsier Pharma Ltd. since 2018 and Head-Global Transactions at Roivant Sciences GmbH.
Former positions include Director at Sumitomo Pharma Switzerland GmbH and Deputy Head-Global M&A at Roche Holding AG from 2009 to 2016.
Education includes an MBA from Harvard Business School.
Sascha Bucher active positions
| Companies | Position | Start |
|---|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Corporate Officer/Principal | - |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Director/Board Member | 01/01/2018 |
Former positions of Sascha Bucher
| Companies | Position | End |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2016 |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Corporate Officer/Principal | - |
Training of Sascha Bucher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Health Technology |
- Stock Market
- Insiders
- Sascha Bucher
















